14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $4.71 $5.41 Wednesday, 24th Apr 2024 AUPH stock ended at $5.03. This is 1.18% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 3.20% from a day low at $5.00 to a day high of $5.16.
90 days $4.71 $8.49
52 weeks $4.71 $12.42

Historical Aurinia Pharmaceuticals Inc prices

Date Open High Low Close Volume
Jun 07, 2021 $12.70 $13.00 $12.36 $12.88 3 239 387
Jun 04, 2021 $12.97 $13.30 $12.38 $12.48 3 885 980
Jun 03, 2021 $13.86 $14.07 $12.79 $12.80 5 678 954
Jun 02, 2021 $14.15 $14.41 $13.78 $13.87 3 180 189
Jun 01, 2021 $14.75 $14.79 $13.86 $14.14 2 751 250
May 28, 2021 $14.33 $15.00 $14.26 $14.52 4 080 947
May 27, 2021 $14.07 $14.29 $13.83 $14.24 3 397 266
May 26, 2021 $13.39 $14.37 $13.30 $14.13 4 344 700
May 25, 2021 $12.90 $13.43 $12.81 $13.25 3 107 390
May 24, 2021 $13.15 $13.30 $12.63 $12.65 2 882 836
May 21, 2021 $13.13 $13.37 $12.89 $13.04 3 993 013
May 20, 2021 $12.85 $13.05 $12.69 $12.82 1 712 547
May 19, 2021 $12.74 $13.19 $12.69 $12.82 2 561 696
May 18, 2021 $12.20 $13.43 $12.20 $13.05 3 996 229
May 17, 2021 $12.14 $12.30 $11.85 $12.29 3 908 796
May 14, 2021 $11.02 $11.97 $11.02 $11.92 5 463 670
May 13, 2021 $11.64 $11.91 $10.81 $10.96 5 956 230
May 12, 2021 $11.05 $11.74 $11.00 $11.29 7 244 596
May 11, 2021 $9.74 $11.34 $9.72 $11.23 10 092 402
May 10, 2021 $10.42 $10.49 $9.91 $10.00 5 125 400
May 07, 2021 $10.68 $10.81 $10.03 $10.15 14 380 982
May 06, 2021 $13.24 $13.25 $12.02 $12.34 8 602 599
May 05, 2021 $12.31 $12.49 $12.04 $12.27 3 360 036
May 04, 2021 $12.52 $12.61 $11.93 $12.19 3 460 868
May 03, 2021 $13.56 $13.57 $12.53 $12.56 4 904 466
Click to get the best stock tips daily for free!

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.... AUPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT